Compound Summary
PD 169316
Compound Information
PD 169316
Compound Name: | PD 169316 |
Compound CID: | 4712 |
Synonyms: | PD 169316 152121-53-4 PD-169316 PD169316 4-(4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)pyridine More... |
Iupac Name: | 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]pyridine |
InChI: | InChI=1S/C20H13FN4O2/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(8-4-15)25(26)27/h1-12H,(H,23,24) |
InChIKey: | BGIYKDUASORTBB-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)[N+](=O)[O-] |
Isomeric Smiles: | C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)[N+](=O)[O-] |
Molecular Weight: | 360.3 |
Molecular Formula: | C20H13FN4O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
PD 169316
Molecular Weight: | 360.3 |
Molecular Formula: | C20H13FN4O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 27 |
Complexity: | 495 |
Synonyms
PD 169316
| PD 169316 | PD 169316 |
|---|---|
PD 169316 |
152121-53-4 |
PD-169316 |
PD169316 |
4-(4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)pyridine |
4-4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-ylpyridine |
4-(4-Fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole |
UNII-GX3Y2V80CV |
PD168316 |
GX3Y2V80CV |
CHEMBL17331 |
2-(4-Nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole |
MFCD12405019 |
C20H13FN4O2 |
4-(5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl)pyridine |
Pyridine, 4-(4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)- |
J1.342.800J |
CBiol_002019 |
cc-565 |
SCHEMBL154958 |
GTPL6016 |
SCHEMBL9899161 |
DTXSID8042684 |
CHEBI:93358 |
AOB6757 |
EX-A219 |
SB-203580 analogue (1) |
BCPP000122 |
Bio1_000305 |
Bio1_000794 |
Bio1_001283 |
HMS3229M10 |
HMS3261A04 |
HMS3649N16 |
BCP02234 |
ZINC8536496 |
Tox21_500401 |
BDBM50230001 |
HSCI1_000116 |
s5183 |
AKOS015994573 |
AKOS024464733 |
Pyridine, 4-(5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl)- |
BCP9001064 |
CCG-206874 |
CCG-221705 |
CS-1711 |
ES-0028 |
LP00401 |
LS41097 |
QC-8219 |
SDCCGSBI-0086779.P002 |
NCGC00093828-01 |
NCGC00093828-02 |
NCGC00093828-03 |
NCGC00093828-04 |
NCGC00093828-05 |
NCGC00093828-06 |
NCGC00093828-14 |
NCGC00261086-01 |
AC-31396 |
HY-10578 |
PD169317 |
AB0032411 |
EU-0100401 |
FT-0673539 |
P2532 |
PD 169,316 |
X5714 |
A25448 |
PD 169316, >=98% (HPLC), solid |
SR-01000838075 |
J-008892 |
J-514243 |
SR-01000838075-3 |
BRD-K77133231-001-01-1 |
Q27088275 |
PD 169316 - CAS 152121-53-4 |
4-4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl-pyridine |
4-5-(4-Fluoro-phenyl)-2-(4-nitro-phenyl)-3H-imidazol-4-yl-pyridine |
Pyridine,4-4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl- |
PD 169316 4-4-(4-Fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-ylpyridine |
Experimental Data
PD 169316
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -21.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
PD 169316
Statistics Data
PD 169316
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -21.000000000000000 | 1 | 1 |
Statistics Data Visualization
PD 169316
